Market Cap
$1.8M
CRIS
CURIS INC
$0.8034 ▼ -3.20%
Prev close $0.8300Market cap$1.8M
ConsensusStrong Buy
12-mo target$42.67 (+5210.8%)
▲ Bullish
Analyst conviction 9/10
High Impact Filing (7/10)4 New Institutional Positions3 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on CRIS right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Analyst Consensus
Strong Buy (90%)
Inst. Holders
24 funds
Inst. Value
$835.5K
Inst. Activity
4 buys / 3 sells
Insider Activity
$5.5K buy / $0.00 sell
Insider Net $
$5.5K
SEC Reports
7
Price chart 30d -41.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 13, 2026 SEC
Curis Inc.'s S-1 registration statement (File No. 333-298203) was declared effective by the SEC on August 12, 2026, unde
EFFECT — Impact 6/10
Aug 12, 2026 short_volume
Jul 30, 2026 SEC Short Volume: CRIS — 77.9% short (0.4M / 0.5M)
Short: 423,990 | Exempt: 42,610 | TRF Vol: 544,172 | Short Ratio: 77.9% | Off-exchange volume (dark
Curis Inc. received Nasdaq notice confirming it has regained compliance with the Bid Price Rule (Rule 5550(a)(2)) and is
8-K — Impact 6/10
Jul 7, 2026 Insider
GREENACRE MARTYN D was granted 6,800 shares
Director @ $5.29 ($36.0K)
Jul 7, 2026 Insider
KAITIN KENNETH I was granted 6,800 shares
Director @ $5.29 ($36.0K)
Jul 7, 2026 Insider
Jul 3, 2026 SEC Rubin Marc was granted 6,800 shares
Director @ $5.29 ($36.0K)
Curis Inc. filed a certificate of amendment to effect a 1-for-20 reverse stock split of its common stock, effective July
8-K — Impact 3/10
Mar 31, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
366,740 shares ($200.7K)
Analyst ratings buy % -1.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
90% rate it Buy or better · 10 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 17, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Jul 24, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Aug 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Jul 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Jun 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| May 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Apr 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Mar 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% |
Price targets
Where 3 covering analysts think CRIS trades over the next 12 months.
$42.67 +5210.8% upside Strong Buy
Current$0.8034 Low$20.00 Median$43.00 High$65.00 3 analysts
$20.00$65.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 1 bullish, 4 bearish, 0 mixed, 2 neutral · avg impact 5.7/10.
BEARISHEFFECT6/10
Curis Inc.'s S-1 registration statement (File No. 333-298203) was declared effective by the SEC on A
Aug 13, 2026
BULLISH8-K6/10
Curis Inc. received Nasdaq notice confirming it has regained compliance with the Bid Price Rule (Rul
Jul 30, 2026
NEUTRAL8-K3/10
Curis Inc. filed a certificate of amendment to effect a 1-for-20 reverse stock split of its common s
Jul 3, 2026
BEARISH8-K6/10
Curis Inc. shareholders approved a charter amendment at the May 19, 2026 annual meeting to nearly do
May 22, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 12, 2026
short_volume
Short Volume: CRIS — 77.9% short (0.4M / 0.5M)
Short: 423,990 | Exempt: 42,610 | TRF Vol: 544,172 | Short Ratio: 77.9% | Off-exchange volume (dark pool + OTC)
Aug 3, 2026
earnings_calendar
CRIS Q2 2026 Earnings Scheduled — 2026-08-03
Jul 25, 2026
listing_status
Listing Status: CRIS — Normal (was Deficient)
Curis, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Jul 6, 2026
other
Curis Consents First Six Patients in TakeAim CLL Study
LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948)
Jul 6, 2026
trading_halt
Halt Resumed: CRIS — trading resumed after T3 (News and Resumption Times)
Halted 2026-07-02T23:50:00.000Z | Resumed 2026-07-06T13:00:00.000Z
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-2.01 | $-2.29–$-1.73 | 79.5% | +70.1% | 1↑ 0↓ | $0.0B | 2 |
| Next Q | $-1.63 | $-1.75–$-1.50 | 83.7% | +75.1% | 1↑ 0↓ | $0.0B | 2 |
| Current FY | $-23.78 | $-32.48–$-15.65 | 55.0% | +23.8% | 1↑ 0↓ | $0.0B | 3 |
| Next FY | $-6.01 | $-7.99–$-3.17 | 74.7% | +74.7% | 2↑ 0↓ | $0.0B | 3 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-2.010 | — |
| 7d ago | $-5.063 | +3.053 |
| 30d ago | $-6.733 | +4.723 |
| 60d ago | $-6.733 | +4.723 |
| 90d ago | $-6.733 | +4.723 |
Institutional ownership
Which big funds own CRIS (from quarterly 13F filings) and who is adding or trimming.
24 institutional holders with $835.5K total value (1,555,085 shares) as of 2026-Q1. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net buying activity: 4 institutions added/increased vs 3 reduced.
Top holders — 2026-Q1
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 374,326 | $204.8K | 24.5% | — |
| RENAISSANCE TECHNOLOGIES LLC | 366,740 | $200.7K | 24.0% | ADD +52.2% |
| MORGAN STANLEY | 254,245 | $139.1K | 16.7% | DOUBLED +445943.9% |
| GEODE CAPITAL MANAGEMENT, LLC | 168,327 | $92.1K | 11.0% | ADD +66.1% |
| CITADEL ADVISORS LLC | 67,018 | $36.7K | 4.4% | — |
| VANGUARD FIDUCIARY TRUST CO | 61,664 | $33.7K | 4.0% | — |
| Squarepoint Ops LLC | 58,035 | $31.8K | 3.8% | TRIM -32.9% |
| BlackRock, Inc. | 53,484 | $29.3K | 3.5% | — |
| PRUDENTIAL FINANCIAL INC | 35,400 | $19.4K | 2.3% | — |
| JANE STREET GROUP, LLC | 26,295 | $14.4K | 1.7% | ADD +71.8% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | ADD | 240,917 | 366,740 | +52.2% | $200.7K |
| MORGAN STANLEY | DOUBLED | 57 | 254,245 | +445943.9% | $139.1K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 101,328 | 168,327 | +66.1% | $92.1K |
| Squarepoint Ops LLC | TRIM | 86,483 | 58,035 | -32.9% | $31.8K |
| Steward Partners Investment Advisory, LLC | ADD | 1,597 | 2,597 | +62.6% | $1.4K |
| UBS Group AG | NEAR_EXIT | 3,695 | 71 | -98.1% | $39.00 |
| OSAIC HOLDINGS, INC. | NEAR_EXIT | 1,510 | 60 | -96.0% | $33.00 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | DOUBLED | 8 | 230,667 | +2883237.5% | $11.2M |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 175,513 | 240,917 | +37.3% | $237.8K |
| Squarepoint Ops LLC | ADD | 59,140 | 86,483 | +46.2% | $85.4K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 39 transactions. Net $5.5K — $5.5K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | GREENACRE MARTYN D | Director | AWARD | 6,800 | $5.29 | $36.0K |
| Jul 7, 2026 | KAITIN KENNETH I | Director | AWARD | 6,800 | $5.29 | $36.0K |
| Jul 7, 2026 | Rubin Marc | Director | AWARD | 6,800 | $5.29 | $36.0K |
| Jul 7, 2026 | Zung Jonathan B. | CDO | AWARD | 48,285 | $5.29 | $255.4K |
| Jul 7, 2026 | Hohneker John | Director | AWARD | 6,800 | $5.29 | $36.0K |
| Jul 7, 2026 | Duvall Diantha | CFO | AWARD | 48,285 | $5.29 | $255.4K |
| Jul 7, 2026 | Dentzer James E | President & CEO | AWARD | 110,090 | $5.29 | $582.4K |
| Jul 7, 2026 | Borgman Anne Elizabeth | Director | AWARD | 6,800 | $5.29 | $36.0K |
| Mar 31, 2026 | KAITIN KENNETH I | Director | BUY | 10,000 | $0.5487 | $5.5K |
| Mar 20, 2026 | Zung Jonathan B. | CDO | CONVERT | 50 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CRIS.
Shares short
69,025
Settlement Sep 15, 2026
Change vs prior
-59.0%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈3.3%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Jul 2, 2026 | T3 | Resumption Scheduled | Resumed |
All CRIS filing & press-release reports (7)
- EFFECT reportAug 13, 2026
- 8-K reportJul 30, 2026
- 8-K reportJul 3, 2026
- 8-K reportMay 22, 2026
- 8-K reportMay 12, 2026
- 8-K reportMay 1, 2026
- EFFECT reportMar 23, 2026